In mice, TDNPs were found to alleviate colitis symptoms by regulating the expression of pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) and the antioxidant gene HO-1, while also deactivating the NF-κB pathway [87]. This evidence concerns the gene IL1B and colitis.